Sep. 18, 2021

OI338: Oral Insulin Analog Shows Ultralong Half-Life

OI338

oral, ultralong-acting insulin analog effective in Ph. IIa, hum. t1/2~3 d, 4% F dog albumin-binding motif + reduced endocytosis J. Med. Chem., Dec. 28, 2020 Novo Nordisk, Maaloev, DK

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in